• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in COVID-19.伊维菌素的抗病毒和抗炎特性及其在COVID-19中的潜在用途
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):831. doi: 10.1016/j.arbres.2020.06.011. Epub 2020 Jul 7.
2
Reply to "Antiviral and anti-inflammatory properties of ivermectinand its potential use in COVID-19".对“伊维菌素的抗病毒和抗炎特性及其在COVID-19中的潜在用途”的回复
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):833. doi: 10.1016/j.arbres.2020.09.004. Epub 2020 Sep 23.
3
Considerations on the Article "Antiviral and Anti-Inflammatory Properties of Ivermectin and its Potential Use in COVID-19".关于《伊维菌素的抗病毒和抗炎特性及其在COVID-19中的潜在用途》一文的思考
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):832. doi: 10.1016/j.arbres.2020.08.012. Epub 2020 Sep 16.
4
Pandemic and promise: progress towards finding an effective treatment for Novel Coronavirus 19.大流行与希望：在寻找新型冠状病毒19有效治疗方法方面取得的进展。
Aust N Z J Public Health. 2020 Dec;44(6):437-439. doi: 10.1111/1753-6405.13044. Epub 2020 Oct 12.
5
Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19.伊维菌素治疗可能改善新冠肺炎患者的预后。
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):828-830. doi: 10.1016/j.arbres.2020.08.007. Epub 2020 Sep 24.
6
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19.伊维菌素：一种具有抗 COVID-19 预期抗病毒活性的获奖药物。
J Control Release. 2021 Jan 10;329:758-761. doi: 10.1016/j.jconrel.2020.10.009. Epub 2020 Oct 7.
7
COVID-19 update: NIH recommends against ivermectin.新冠疫情最新情况：美国国立卫生研究院不建议使用伊维菌素。
Med Lett Drugs Ther. 2022 Jun 13;64(1652):95-96.
8
Ivermectin for preventing and treating COVID-19.伊维菌素预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Jul 28;7(7):CD015017. doi: 10.1002/14651858.CD015017.pub2.
9
Safety cannot justify the use of ivermectin for the management of COVID-19.安全性不能成为使用伊维菌素治疗新冠肺炎的理由。
QJM. 2022 Mar 22;115(3):194-195. doi: 10.1093/qjmed/hcac019.
10
The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?广谱宿主导向药物伊维菌素作为 SARS-CoV-2 的抗病毒药物？
Biochem Biophys Res Commun. 2021 Jan 29;538:163-172. doi: 10.1016/j.bbrc.2020.10.042. Epub 2020 Oct 21.

引用本文的文献

1
Niclosamide, but not ivermectin, inhibits anoctamin 1 and 6 and attenuates inflammation of the respiratory tract.尼克罗米胺而非伊维菌素抑制钙激活氯通道蛋白 1 和 6，减轻呼吸道炎症。
Pflugers Arch. 2024 Feb;476(2):211-227. doi: 10.1007/s00424-023-02878-w. Epub 2023 Nov 18.
2
Synthesis and evaluation of the effects of solid lipid nanoparticles of ivermectin and ivermectin on cuprizone-induced demyelination via targeting the TRPA1/NF-kB/GFAP signaling pathway.伊维菌素固体脂质纳米粒对通过靶向TRPA1/NF-κB/GFAP信号通路的铜离子螯合剂诱导脱髓鞘的作用的合成与评价 。 你提供的原文中存在重复表述，“ivermectin and ivermectin”，这里按正确理解翻译了。若有其他需求可继续向我提问。
Iran J Basic Med Sci. 2023;26(11):1272-1282. doi: 10.22038/IJBMS.2023.71309.15493.
3
COVID-19 signalome: Potential therapeutic interventions.COVID-19 信号组：潜在的治疗干预措施。
Cell Signal. 2023 Mar;103:110559. doi: 10.1016/j.cellsig.2022.110559. Epub 2022 Dec 13.
4
A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19.几种治疗新型冠状病毒肺炎的药物疗效综述
Life (Basel). 2022 Nov 1;12(11):1758. doi: 10.3390/life12111758.
5
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.二甲双胍、伊维菌素和氟伏沙明治疗 COVID-19 的随机试验。
N Engl J Med. 2022 Aug 18;387(7):599-610. doi: 10.1056/NEJMoa2201662.
6
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19.综述表明伊维菌素在 COVID-19 预防和治疗中的疗效的新证据。
Am J Ther. 2021 Apr 22;28(3):e299-e318. doi: 10.1097/MJT.0000000000001377.
7
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines.伊维菌素用于预防和治疗 COVID-19 感染：系统评价、荟萃分析和试验序贯分析，为临床指南提供信息。
Am J Ther. 2021 Jun 21;28(4):e434-e460. doi: 10.1097/MJT.0000000000001402.
8
Reply to "Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19".对“伊维菌素的抗病毒和抗炎特性及其在新冠病毒疾病中的潜在用途”的回复
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):833. doi: 10.1016/j.arbr.2020.11.002. Epub 2020 Nov 6.
9
Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19.伊维菌素治疗可能改善新冠病毒肺炎患者的预后。
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):828-830. doi: 10.1016/j.arbr.2020.08.011. Epub 2020 Dec 14.
10
Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico.由伊维菌素、阿奇霉素、孟鲁司特和乙酰水杨酸组成的多药疗法对墨西哥特拉斯卡拉门诊COVID-19病例预防住院和死亡的有效性。
Int J Infect Dis. 2021 Apr;105:598-605. doi: 10.1016/j.ijid.2021.02.014. Epub 2021 Feb 10.

本文引用的文献

1
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19.伊维菌素单独批准的剂量不是治疗 COVID-19 的理想剂量。
Clin Pharmacol Ther. 2020 Oct;108(4):762-765. doi: 10.1002/cpt.1889. Epub 2020 Jun 7.
2
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus.伊维菌素是一种特异性抑制剂，可以抑制 HIV-1 和登革热病毒的复制，其作用机制为抑制核输入蛋白 importin α/β 介导的核输入。
Biochem J. 2012 May 1;443(3):851-6. doi: 10.1042/BJ20120150.
3
Anti-inflammatory effects of ivermectin in mouse model of allergic asthma.伊维菌素对过敏性哮喘小鼠模型的抗炎作用。
Inflamm Res. 2011 Jun;60(6):589-96. doi: 10.1007/s00011-011-0307-8. Epub 2011 Jan 29.
4
Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice.伊维菌素可抑制脂多糖诱导的炎性细胞因子生成，并提高脂多糖诱导的小鼠存活率。
Inflamm Res. 2008 Nov;57(11):524-9. doi: 10.1007/s00011-008-8007-8.

Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in COVID-19.

作者信息

Portmann-Baracco Arianna, Bryce-Alberti Mayte, Accinelli Roberto Alfonso

机构信息

Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Perú.

Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Perú; Servicio de Neumología, Hospital Cayetano Heredia, Lima, Perú; Instituto de Investigaciones de la Altura. Universidad Peruana Cayetano Heredia, Lima, Perú.

出版信息

Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):831. doi: 10.1016/j.arbres.2020.06.011. Epub 2020 Jul 7.

DOI:10.1016/j.arbres.2020.06.011
PMID:32736876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7340065/
Abstract
摘要